These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 6408173)

  • 1. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
    Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
    J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a human B cell-specific antigen (B2) distinct from B1.
    Nadler LM; Stashenko P; Hardy R; van Agthoven A; Terhorst C; Schlossman SF
    J Immunol; 1981 May; 126(5):1941-7. PubMed ID: 6163824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
    Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
    J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B5, a new B cell-restricted activation antigen.
    Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human B-lymphocyte antigen shared with lymphoid dendritic cells: characterization by monoclonal antibody.
    Ishii Y; Takami T; Kokai Y; Yuasa H; Fujimoto J; Takei T; Kikuchi K
    Clin Exp Immunol; 1985 Sep; 61(3):624-32. PubMed ID: 3907905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
    Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7, a B-cell-restricted antigen that identifies preactivated B cells.
    Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
    J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
    Storkus WJ; Dawson JR
    J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
    J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigens on human plasma cells identified by monoclonal antibodies.
    Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
    J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
    Fraser JK; Berridge MV
    Exp Hematol; 1987 May; 15(4):406-13. PubMed ID: 2952519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
    Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
    Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
    Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
    J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma.
    Aida Y; Okada K; Amanuma H
    Cancer Res; 1993 Jan; 53(2):429-37. PubMed ID: 8380256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
    Miller RA; Gralow J
    J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.